Company: MLTX
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001140361-25-014923
Chunk: 1

Company: MoonLake Immunotherapeutics
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 1
---
 independent registered public accounting firm for the year ending December 31, 2025; |

| (3) | To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers; and |

| (4) | To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof. |

The Board of Directors has fixed April 10, 2025 as the record date. Only shareholders of record at the close of business on that date will be entitled to notice of, and to attend and vote at the Annual Meeting or any adjournment or postponement thereof. By Order of the Board of Directors /s/ Dr. Jorge Santos da Silva Dr. Jorge Santos da Silva Chief Executive Officer Zug, Switzerland April 22, 2025 Whether or not you expect to attend the Annual Meeting, please vote as promptly as possible in order to ensure your representation at the Annual Meeting. You may vote online or, if you requested printed copies of the proxy materials, by telephone or by using the proxy card or voting instruction form provided with the printed proxy materials.

TABLE OF CONTENTS

TABLE OF CONTENTS

|                                                            |     | Page |
| QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND VOTING |     |    1 |
| PROPOSAL 1: ELECTION OF DIRECTORS                          |     |    5 |
| PROPOSAL 2: RATIFICATION OF INDEPENDENT AUDITOR SELECTION  |     |    8 |
| PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION        |     |   10 |
| CORPORATE GOVERNANCE                                       |     |   11 |
| EXECUTIVE OFFICERS                                         |     |   18 |
| EXECUTIVE COMPENSATION                                     |     |   19 |
| COMPENSATION DISCUSSION AND ANALYSIS                       |     |   19 |
| REPORT OF THE COMPENSATION COMMITTEE                       |     |   25 |
| 2024 SUMMARY COMPENSATION TABLE                            |     |   26 |
| 2024 GRANTS OF PLAN-BASED AWARDS TABLE                     |     |   27 |
| OUTSTANDING EQUITY AWARDS AT 2024 FISCAL YEAR END TABLE    |     |   27 |
| OPTION EXERCISES AND STOCK VESTED TABLE                    |     |   27 |
| FISCAL YEAR